治疗哮喘的消炎缓解疗法（AIR）。

IF 4.3 3区医学 Q1 RESPIRATORY SYSTEM

ERJ Open Research Pub Date : 2024-09-30 eCollection Date: 2024-09-01 DOI:10.1183/23120541.00494-2024

Mark L Levy, Michael G Crooks

引用次数: 0

摘要

在哮喘患者中，SABA 的过度使用非常普遍且危险。在哮喘中使用抗炎镇痛剂（ICS/福莫特罗）可减轻与 SABA 过度使用和 ICS 依从性差相关的风险，是哮喘治疗的首选方法。https://bit.ly/4aHOLn8。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Anti-inflammatory reliever therapy (AIR) for asthma.

SABA overuse is prevalent and dangerous in asthma. Use of anti-inflammatory relievers (ICS/formoterol) in asthma mitigates against risk associated with SABA overuse and poor ICS adherence, and is the preferred approach for asthma management. https://bit.ly/4aHOLn8.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

ERJ Open Research Medicine-Pulmonary and Respiratory Medicine

CiteScore

6.20

自引率

4.30%

发文量

273

审稿时长

8 weeks

期刊介绍： ERJ Open Research is a fully open access original research journal, published online by the European Respiratory Society. The journal aims to publish high-quality work in all fields of respiratory science and medicine, covering basic science, clinical translational science and clinical medicine. The journal was created to help fulfil the ERS objective to disseminate scientific and educational material to its members and to the medical community, but also to provide researchers with an affordable open access specialty journal in which to publish their work.